SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 325 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,181,620 | -45.8% | 174,737 | -48.8% | 0.01% | -40.0% |
| Q2 2023 | $39,114,307 | -17.6% | 341,550 | -0.9% | 0.01% | -23.1% |
| Q1 2023 | $47,495,253 | +65.9% | 344,593 | +56.0% | 0.01% | +62.5% |
| Q4 2022 | $28,620,463 | +49.0% | 220,871 | +27.1% | 0.01% | +33.3% |
| Q3 2022 | $19,206,000 | +71.3% | 173,750 | +16.2% | 0.01% | +100.0% |
| Q2 2022 | $11,211,000 | +135.2% | 149,558 | +145.2% | 0.00% | +200.0% |
| Q1 2022 | $4,766,000 | -10.0% | 61,006 | +3.8% | 0.00% | 0.0% |
| Q4 2021 | $5,293,000 | -51.2% | 58,773 | -49.9% | 0.00% | -66.7% |
| Q3 2021 | $10,849,000 | +33.8% | 117,305 | +12.5% | 0.00% | +50.0% |
| Q2 2021 | $8,107,000 | +13.8% | 104,279 | +9.1% | 0.00% | 0.0% |
| Q1 2021 | $7,125,000 | -97.1% | 95,598 | -93.4% | 0.00% | -97.2% |
| Q4 2020 | $245,742,000 | +59.8% | 1,441,384 | +31.6% | 0.07% | +38.5% |
| Q3 2020 | $153,765,000 | -18.1% | 1,094,960 | -6.5% | 0.05% | -22.4% |
| Q2 2020 | $187,820,000 | +23.5% | 1,171,394 | -24.7% | 0.07% | +4.7% |
| Q1 2020 | $152,078,000 | -34.7% | 1,554,669 | -13.9% | 0.06% | -11.1% |
| Q4 2019 | $232,898,000 | +70.0% | 1,804,853 | -0.8% | 0.07% | +100.0% |
| Q3 2019 | $137,010,000 | -49.6% | 1,819,026 | +1.6% | 0.04% | -48.6% |
| Q2 2019 | $272,088,000 | +121.3% | 1,790,640 | +73.6% | 0.07% | +70.7% |
| Q1 2019 | $122,975,000 | +15.4% | 1,031,752 | +5.6% | 0.04% | 0.0% |
| Q4 2018 | $106,582,000 | -41.9% | 976,651 | -14.0% | 0.04% | -29.3% |
| Q3 2018 | $183,369,000 | +45.0% | 1,135,342 | +18.7% | 0.06% | +38.1% |
| Q2 2018 | $126,441,000 | +185.5% | 956,582 | +60.1% | 0.04% | +147.1% |
| Q1 2018 | $44,281,000 | +113.8% | 597,666 | +60.6% | 0.02% | +142.9% |
| Q4 2017 | $20,710,000 | +27.9% | 372,218 | +4.3% | 0.01% | +16.7% |
| Q3 2017 | $16,190,000 | +34.7% | 356,921 | +0.1% | 0.01% | +50.0% |
| Q2 2017 | $12,020,000 | +12.5% | 356,564 | -1.2% | 0.00% | 0.0% |
| Q1 2017 | $10,687,000 | -14.7% | 361,041 | -20.9% | 0.00% | 0.0% |
| Q4 2016 | $12,524,000 | -60.4% | 456,598 | -11.3% | 0.00% | -63.6% |
| Q3 2016 | $31,615,000 | +350.5% | 514,823 | +39.9% | 0.01% | +266.7% |
| Q2 2016 | $7,017,000 | -8.1% | 367,987 | -5.9% | 0.00% | 0.0% |
| Q1 2016 | $7,635,000 | -65.6% | 391,168 | -31.9% | 0.00% | -66.7% |
| Q4 2015 | $22,173,000 | +123.6% | 574,738 | +86.1% | 0.01% | +125.0% |
| Q3 2015 | $9,918,000 | -35.7% | 308,872 | -39.0% | 0.00% | -33.3% |
| Q2 2015 | $15,418,000 | +9132.3% | 506,676 | +3925.1% | 0.01% | – |
| Q1 2015 | $167,000 | -96.1% | 12,588 | -86.2% | 0.00% | -100.0% |
| Q3 2013 | $4,307,000 | – | 91,192 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |